
Cingulate Inc.
CINGHealthcare|Biotechnology|US
$4.26
+0.02 (+0.47%)
DCF Value
$0.05
Tangible Book / Share
$4.32
Cash / Share
$5.23
Next Earnings Report
Nov 12, 2026
EPS est. -$0.48 · Revenue est. $540.0K
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Apr 28, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
Sep 17, 2026 · GlobeNewsWire
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Aug 13, 2026 · GlobeNewsWire
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301's Differentiated Pharmacokinetic Profile
Aug 11, 2026 · GlobeNewsWire
SEC Filings (81)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 2, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 23, 2026 | 8-K | Material event | DocumentIndex |
| Jul 15, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |
| Jul 2, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| May 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | 8-K | Material event | DocumentIndex |
| Apr 28, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 24, 2026 | EFFECT | DocumentIndex | |
| Apr 14, 2026 | S-3 | Shelf registration | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Mar 26, 2026 | EFFECT | DocumentIndex | |
| Mar 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 24, 2026 | EFFECT | DocumentIndex | |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Mar 24, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Mar 23, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Mar 20, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 18, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 18, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 18, 2026 | 8-K | Material event | DocumentIndex |
| Mar 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 18, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 17, 2026 | 8-K | Material event | DocumentIndex |
| Feb 9, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Feb 6, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Jan 15, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 12, 2026 | 424B5 | Offering prospectus | DocumentIndex |